|
1
|
Marioni G, Marchese-Ragona R, Cartei G,
Marchesex F and Staffieri A: Current opinion in diagnosis and
treatment of laryngeal carcinoma. Cancer Treat Rev. 32:504–515.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kim J, Kim H, Lee Y, Yang K, Byun S and
Han K: A simple and economical short-oligonucleotide-based approach
to shRNA generation. J Biochem Mol Biol. 39:329–334. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mendell JT: MicroRNAs: critical regulators
of development, cellular physiology and malignancy. Cell Cycle.
4:1179–1184. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang HJ, Ruan HJ, He XJ, Ma YY, Jiang XT,
Xia YJ, Ye ZY and Tao HQ: MicroRNA-101 is down-regulated in gastric
cancer and involved in cell migration and invasion. Eur J Cancer.
46:2295–2303. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Majid S, Dar AA, Saini S, Yamamura S,
Hirata H, Tanaka Y, Deng G and Dahiya R: MicroRNA-205-directed
transcriptional activation of tumor suppressor genes in prostate
cancer. Cancer. 116:5637–5649. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rogler CE, Levoci L, Ader T, Massimi A,
Tchaikovskaya T, Norel R and Rogler LE: MicroRNA-23b cluster
microRNAs regulate transforming growth factor-beta/bone
morphogenetic protein signaling and liver stem cell differentiation
by targeting Smads. Hepatology. 50:575–584. 2009. View Article : Google Scholar
|
|
8
|
Mishra PJ, Humeniuk R, Mishra PJ,
Longo-Sorbello GS, Banerjee D and Bertino JR: A miR-24 microRNA
binding-site polymorphism in dihydrofolate reductase gene leads to
methotrexate resistance. Proc Natl Acad Sci USA. 104:13513–13518.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lal A, Navarro F, Maher CA, Maliszewski
LE, Yan N, O'Day E, Chowdhury D, Dykxhoorn DM, Tsai P, Hofmann O,
Becker KG, Gorospe M, Hide W and Lieberman J: miR-24 inhibits cell
proliferation by targeting E2F2, MYC, and other cell-cycle genes
via binding to ‘seedless’ 3'UTR microRNA recognition elements. Mol
Cell. 35:610–625. 2009.PubMed/NCBI
|
|
10
|
Wang Q, Huang Z, Xue H, Jin C, Ju XL, Han
JD and Chen YG: MicroRNA miR-24 inhibits erythropoiesis by
targeting activin type I receptor ALK4. Blood. 111:588–595. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lal A, Kim HH, Abdelmohsen K, Kuwano Y,
Pullmann R Jr, Srikantan S, Subrahmanyam R, Martindale JL, Yang X,
Ahmed F, Navarro F, Dykxhoorn D, Lieberman J and Gorospe M:
p16(INK4a) translation suppressed by miR-24. PLoS One. 3:e18642008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lin SC, Liu CJ, Lin JA, Chiang WF, Hung PS
and Chang KW: miR-24 up-regulation in oral carcinoma: positive
association from clinical and in vitro analysis. Oral Oncol.
46:204–208. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
O'Hara AJ, Chugh P, Wang L, Netto EM, Luz
E, Harrington WJ, Dezube BJ, Damania B and Dittmer DP: Pre-micro
RNA signatures delineate stages of endothelial cell transformation
in Kaposi sarcoma. PLoS Pathog. 5:e10003892009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guo Y, Liu J, Xu Z, Sun K and Fu W: HLA-B
gene participates in the NF-kappaB signal pathway partly by
regulating S100A8 in the laryngeal carcinoma cell line Hep2. Oncol
Rep. 19:1453–1459. 2008.PubMed/NCBI
|
|
15
|
Hsu SD, Chu CH, Tsou AP, Chen SJ, Chen HC,
Hsu PW, Wong YH, Chen YH, Chen GH and Huang HD: miRNAMap 2.0:
genomic maps of microRNAs in metazoan genomes. Nucleic Acids Res.
36:D165–D169. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Smeets SJ, Braakhuis BJ, Abbas S, Snijders
PJ, Ylstra B, van de Wiel MA, Meijer GA, Leemans CR and Brakenhoff
RH: Genome-wide DNA copy number alterations in head and neck
squamous cell carcinomas with or without oncogene-expressing human
papillomavirus. Oncogene. 25:2558–2564. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yu YH, Kuo HK and Chang KW: The evolving
transcriptome of head and neck squamous cell carcinoma: a
systematic review. PLoS One. 3:e32152008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang S, He X, Ding J, Liang L, Zhao Y,
Zhang Z, Yao X, Pan Z, Zhang P, Li J, Wan D and Gu J: Upregulation
of miR-23a approximately 27a approximately 24 decreases
transforming growth factor-beta-induced tumor-suppressive
activities in human hepatocellular carcinoma cells. Int J Cancer.
123:972–978. 2008. View Article : Google Scholar
|
|
19
|
Liu X, Wang A, Heidbreder CE, Jiang L, Yu
J, Kolokythas A, Huang L, Dai Y and Zhou X: MicroRNA-24 targeting
RNA-binding protein DND1 in tongue squamous cell carcinoma. FEBS
Lett. 584:4115–4120. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mitchell PS, Parkin RK, Kroh EM, Fritz BR,
Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant
KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt
DL, Gentleman R, Vessella RL, Nelson PS, Martin DB and Tewari M:
Circulating microRNAs as stable blood-based markers for cancer
detection. Proc Natl Acad Sci USA. 105:10513–10518. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Guan Y, Yao H, Zheng Z, Qiu G and Sun K:
miR-125b targets BCL3 and suppresses ovarian cancer proliferation.
Int J Cancer. 128:2274–2283. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Qin W, Shi Y, Zhao B, Yao C, Jin L, Ma J
and Jin Y: miR-24 regulates apoptosis by targeting the open reading
frame (ORF) region of FAF1 in cancer cells. PLoS One. 5:e94292010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sethupathy P, Megraw M and Hatzigeorgiou
AG: A guide through present computational approaches for the
identification of mammalian microRNA targets. Nat Methods.
3:881–886. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gebhardt C, Breitenbach U, Tuckermann JP,
Dittrich BT, Richter KH and Angel P: Calgranulins S100A8 and S100A9
are negatively regulated by glucocorticoids in a c-Fos-dependent
manner and overexpressed throughout skin carcinogenesis. Oncogene.
21:4266–4276. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gebhardt C, Németh J, Angel P and Hess J:
S100A8 and S100A9 in inflammation and cancer. Biochem Pharmacol.
72:1622–1631. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rahman I: Oxidative stress, chromatin
remodeling and gene transcription in inflammation and chronic lung
diseases. J Biochem Mol Biol. 36:95–109. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yao R, Davidson DD, Lopez-Beltran A,
MacLennan GT, Montironi R and Cheng L: The S100 proteins for
screening and prognostic grading of bladder cancer. Histol
Histopathol. 22:1025–1032. 2007.PubMed/NCBI
|
|
28
|
Huang DF, Fu WN, Guo Y, Xu ZM, Sun XH and
Sun KL: S100A8 mediates the activation of
P65/HLA-B/S100A8/BCL-2/Caspase-9(-3) pathway in laryngeal
carcinogenesis. Chinese Sci Bull. 53:2017–2024. 2008. View Article : Google Scholar
|
